Skip to main navigation
  • Facebook
  • Twitter
  • Instagram
+1 (866) 450-4223 sales@drmtchdev.wpengine.com

Investor Relations

  • Products
    • PLA
      • For Physicians
      • For Patients
    • Carcinome
    • Inflammatory
  • About Us
    • Meet Our Team
    • Careers
    • Contact Us
  • Collaborations
  • News
  • Publications
  • Physician Resources
  • Patient Services
  • Investor Relations
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Contact IR
      • Email Alerts
DermTech

Press Releases

3

Investor Relations

  • Press Releases
  • Events
  • Presentations

Press Releases

Sep 21, 2023
DermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4)
Sep 19, 2023
DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)
Sep 11, 2023
DermTech Appoints Mark Aguillard as Chief Commercial Officer
Aug 25, 2023
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 03, 2023
DermTech Reports Second-Quarter 2023 Financial Results
Jul 19, 2023
DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
Jul 17, 2023
DermTech Announces Release Date for Second-Quarter 2023 Financial Results
Jul 12, 2023
DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
Jun 28, 2023
DermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline Operations
Jun 14, 2023
ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 33

Investor Tools

Print
Email Page
Email Alerts
RSS Feeds
Contact IR

Products

  • PLA for Physicians
  • PLA for Patients
  • Carcinome
  • Inflammatory Disease

About Us

  • Meet Our Team
  • Licensing
  • Collaborations
  • Investor Relations
  • Publications
  • Contact Us
  • Careers
  • Privacy Policy

News

  • Media Coverage
  • Press Releases
  • Physician Blog

Follow Us

Footer Column Last

Physician Portal

Find a Physician

Copyright © 2023 DermTech. All Rights Reserved.
We use cookies to improve your experience on the DermTech website. Accept Privacy Policy